hsa-mir-99a |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
|
|
cell line (W1) |
hsa-mir-99a |
Topotecan |
60699 |
NSC609699 |
approved |
resistant |
|
|
|
cell line (W1) |
hsa-mir-99a |
Vincristine |
5978 |
|
approved |
resistant |
|
|
|
cell line (W1) |
hsa-mir-99a |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (A549) |
hsa-mir-99a |
Androstenedione |
6128 |
NSC9563 |
|
resistant |
|
|
|
cell line (MCF-7) |
hsa-mir-99a |
Androstenedione+Anastrozole |
|
|
|
resistant |
|
|
|
cell line (MCF-7) |
hsa-mir-99a |
Androstenedione+Letrozole |
|
|
|
resistant |
|
|
|
cell line (MCF-7) |
hsa-mir-99a |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (OE19) |
hsa-mir-99a |
Fluorouracil |
3385 |
NSC19893 |
approved |
sensitive |
|
|
|
cell line (KYSE) |
hsa-mir-99a |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (BxPC3) |
hsa-mir-99a |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (SGC-7901) |
hsa-mir-99a |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (BGC-823) |
hsa-miR-99a-5p |
(2R,6R,7R,12S)-9-tert-butyl-16-methoxy-4-phenyl-4,20-diazapentacyclo[11.7.0.02,6.07,12.014,19]icosa-1(13),14(19),15,17-tetraene-3,5-dione |
371264 |
NSC645323 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
(3E)-3-[[3-[1-(4-fluorophenyl)sulfonylpiperidin-4-yl]imidazo[1,5-a]pyridin-1-yl]methylidene]-1H-indol-2-one |
54613720 |
NSC750970 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
(4Z)-4-[(4-chlorophenyl)methylidene]-2-[(2E)-2-(2,3,4,5,6-pentahydroxyhexylidene)hydrazinyl]-1H-imidazol-5-one |
135484999 |
NSC685272 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
(5e)-5-[(3,4-dimethoxyphenyl)methylidene]-3-phenyl-2-propylimino-1,3-thiazolidin-4-one |
5471348 |
NSC710598 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
(9-methoxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazol-2-ium-2-yl)methyl benzoate;iodide |
365242 |
NSC632620 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
(9,10-dioxoanthracen-2-yl)methyl 3-benzamido-2-hydroxy-3-phenylpropanoate |
361915 |
NSC625350 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
(E)-3-(2-nitrophenyl)-1-(3,6,7-trimethyl-4-oxido-1-oxoquinoxalin-1-ium-2-yl)prop-2-en-1-one |
5351352 |
NSC621486 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
(Z)-but-2-enedioic acid;4-(dimethylamino)-1-[6-[4-(dimethylamino)butanoyl]-9-ethylcarbazol-3-yl]butan-1-one |
6450892 |
NSC292816 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
[(6aS,11aR)-2,3,8-trimethoxy-6-methyl-5,11-dioxo-6a,11a-dihydroindeno[1,2-c]isoquinolin-9-yl] methanesulfonate |
341886 |
NSC376254 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
[(z)-[4-(2,4-dichloroanilino)-2-oxo-1-naphthylidene]amino]thiourea |
3000994 |
NSC657676 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
[2-methoxy-3-[methyl(octadecyl)amino]propyl] 2-(trimethylazaniumyl)ethyl phosphate |
131968 |
NSC643828 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
[3,4,5-triacetyloxy-6-[(4Z)-4-[(4-chlorophenyl)methylidene]-5-oxo-1-prop-2-enylimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate |
5470570 |
NSC703037 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
[3,4,5-triacetyloxy-6-[3-cyano-4-(furan-2-yl)-6-(4-methoxyphenyl)-2-oxopyridin-1-yl]oxan-2-yl]methyl acetate |
368875 |
NSC640220 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
[3,4,5-triacetyloxy-6-[3-cyano-4-(furan-2-yl)-6-(4-methoxyphenyl)-2-sulfanylidenepyridin-1-yl]oxan-2-yl]methyl acetate |
383442 |
NSC671809 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
[3,4,5-triacetyloxy-6-[5-[(2-methoxyphenyl)methyl]-3-phenyl-6-sulfanylidene-1,2,4-triazin-1-yl]oxan-2-yl]methyl acetate |
362262 |
NSC625873 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
[4-(4-aminophenyl)sulfonylphenyl]-[4-(4-aminophenyl)sulfonylphenyl]imino-oxidoazanium |
380146 |
NSC665549 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
[6-methoxy-3,4-bis-(4-methylphenyl)sulfonyloxyoxan-2-yl]methyl 4-methylbenzenesulfonate |
359615 |
NSC620674 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
[7-benzyl-6-bromo-2,4-bis(methylsulfanyl)pyrrolo[2,3-d]pyrimidin-5-yl]methanol |
357482 |
NSC616511 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
1-((2-(diethylamino)ethyl)amino)-4-(hydroxy(oxido)amino)-9-imino-9,10-dihydroacridine |
377168 |
NSC658370 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
1-((3-(diethylamino)propyl)amino)-4-(hydroxy(oxido)amino)-9-imino-7-methoxy-9,10-dihydroacridine |
377166 |
NSC658368 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
1-((3-(diethylamino)propyl)amino)-4-(hydroxy(oxido)amino)-9-imino-9,10-dihydroacridine |
377170 |
NSC658372 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
1-[2-(4-methoxyphenyl)-6-morpholin-4-yl-1,3-benzothiazol-5-yl]-3-(4-methylsulfanylphenyl)urea |
54613383 |
NSC747180 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
1-[3-[1-(3-chlorophenyl)-3-(4-methoxyphenyl)pyrazol-4-yl]-5-phenyl-3,4-dihydropyrazol-2-yl]ethanone |
155815904 |
NSC763582 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
12-(3-piperidin-1-ylpropyl)-3-oxa-12-azapentacyclo[11.8.0.02,11.05,10.014,19]henicosa-1(13),2(11),5,7,9,14,16,18,20-nonaen-4-one;hydrochloride |
368096 |
NSC638435 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
13-(4-methylphenyl)sulfonyl-1,4,7,10-tetrathia-13-azacyclopentadecane |
373829 |
NSC650792 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
13-benzoyl-18,19-dimethoxy-5,7-dioxa-13-azapentacyclo[10.7.1.02,10.04,8.016,20]icosa-1(20),2,4(8),9,16,18-hexaene-12-carbonitrile |
363096 |
NSC627666 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
15-[2-(dimethylamino)ethyl]-10-[2-(dimethylamino)ethylamino]-5-methoxy-1,15-diazatetracyclo[7.7.1.02,7.013,17]heptadeca-2(7),3,5,9,11,13(17)-hexaene-8,14,16-trione;hydrochloride |
392061 |
NSC691851 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
15,16-dimethoxy-20-propyl-5,7-dioxa-20-azoniapentacyclo[10.8.0.02,10.04,8.013,18]icosa-1(12),2,4(8),9,13,15,17,19-octaene;chloride |
11811448 |
NSC701812 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
17-[(3s)-3-aminopyrrolidin-1-yl]-18-fluoro-21-oxo-5,15-dioxa-1-azahexacyclo[14.7.1.02,14.04,12.06,11.020,24]tetracosa-2(14),3,6,8,10,12,16(24),17,19,22-decaene-22-carboxylic acid;hydrochloride |
54611538 |
NSC709849 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
2-(1H-imidazol-2-ylmethyl)-5-(1H-imidazol-5-ylmethyl)-1H-imidazole |
370230 |
NSC643000 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
2-(2-(2-(2,4,5-tris(2-(2-(1,3-dioxolan-2-yl)phenoxy)ethoxy)phenoxy)ethoxy)phenyl)-1,3-dioxolane |
374816 |
NSC653153 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
2-(2-hydroxy-3-morpholino-propyl)sulfanyl-4-morpholino-6-phenyl-pyrimidine-5-carbonitrile |
45028927 |
NSC744860 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
2-(3-benzyl-6-methyl-4-oxoquinazolin-2-yl)sulfanyl-N-(3,4,5-trimethoxyphenyl)acetamide |
155809865 |
NSC762988 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
2-(4,5-dimethyl-1,3-dithiol-2-ylidene)-4,6-dimethyl-[1,3]dithiolo[4,5-d]pyrimidine-5,7-dione |
377230 |
NSC658469 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
2-[(hexanoyloxy)methyl]-9-methoxy-5,11-dimethyl-6h-pyrido[4,3-b]carbazol-2-ium iodide |
367403 |
NSC637127 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
2-[[2-[4-[(e)-2-chloro-1,2-diphenylethenyl]phenoxy]ethyl]amino]ethanol |
5466853 |
NSC644607 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
2-[16-(3,4-dimethoxyphenyl)-12,14-diphenyl-10-oxa-3,5,6,8,12,13-hexazatetracyclo[7.7.0.02,6.011,15]hexadeca-1(9),2,4,7,11(15),13-hexaen-4-yl]acetonitrile |
391834 |
NSC691421 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
2-bromo-6-(5-(4-methoxyphenyl)-3-isoxazolyl)-4-methylphenol |
355054 |
NSC607993 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
2-chloro-3-(2-butoxyethoxy)naphthazarin |
135406263 |
NSC661415 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
2-chloro-6-((2-chloro-4-methyl-6-quinolinyl)methyl)-4-methylquinoline |
268954 |
NSC109451 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
2-isonicotinoyl-5-methyl-4-(2-naphthyldiazenyl)-2,4-dihydro-3h-pyrazol-3-one |
327703 |
NSC303769 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
2-methyl-9-[(z)-phenylimino]naphth[2,3-d]oxazol-4-one |
373683 |
NSC650574 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
2-methylthieno[3,2-f][1]benzothiole-4,8-dione |
375901 |
NSC656238 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
2h-1-benzopyran-2-one, 4-(2-benzofuranyl)-7-methoxy- |
364364 |
NSC630375 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
3-(2-aminophenyl)sulfanyl-1-(3,4-dichlorophenyl)pyrrolidine-2,5-dione |
295591 |
NSC164991 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
3-[4-(7-chloroquinolin-4-yl)oxy-3-methoxyphenyl]-5-phenyl-3,4-dihydropyrazole-2-carbaldehyde |
155810020 |
NSC762559 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
3-[6-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)hexyl]-5,5-diphenylimidazolidine-2,4-dione |
343242 |
NSC382386 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
3-hydroxy-n-[3-(trifluoromethyl)phenyl]naphthalene-2-carboxamide |
235600 |
NSC37186 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
4-(1-(4-aminophenyl)-3,4-diphenyl-1h-1.lambda.~4~-thien-1-yl)phenylamine |
392992 |
NSC694234 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
4-(4-fluorophenyl)-2-[8-[[4-(4-fluorophenyl)-5-propyl-1h-imidazol-2-yl]sulfanyl]octylsulfanyl]-5-propyl-1h-imidazole;methanesulfonic acid |
374589 |
NSC652562 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
4-(8-(2,4-dimethoxyphenyl)-7-methyl-7,8-dihydro-6h-[1,3]dioxolo[4,5-g]chromen-6-yl)morpholine |
380570 |
NSC666220 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
4-[1-(3-chlorophenyl)-3-(4-methoxyphenyl)pyrazol-4-yl]-2-oxo-6-phenyl-1H-pyridine-3-carbonitrile |
155809889 |
NSC762934 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
4-[4-(4-chlorophenyl)piperazin-1-yl]-6-(4-methoxyphenyl)-2-oxo-2h-pyran-3-carbonitrile |
360621 |
NSC622926 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
4-chloro-5-phenoxy-3h-1,2-dithiole-3-thione |
16766044 |
NSC729184 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
4-hydroxy-2-isopropenyl-10-methyl-3,10-dihydrofuro[3,2-b]acridin-5(2h)-one |
378566 |
NSC661205 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
5-hydroxy-3,6,8-trimethoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one |
355799 |
NSC610173 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
5,7-dihydroquinolino[3,2-d][1]benzazepine-6-thione |
3005168 |
NSC679092 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
5h-naphtho[2,3-c][1]benzazepine-6,13-dione |
386348 |
NSC678131 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
6-(4-bromo-phenyl)-3-(4-chloro-phenoxymethyl)-7h-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine |
364168 |
NSC629868 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
6-(4-methoxyphenyl)-2-oxo-4-(4-phenylpiperazin-1-yl)-2h-pyran-3-carbonitrile |
360619 |
NSC622924 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
6-(5-aminopentyl)indeno[1,2-c]isoquinoline-5,11-dione;hydrochloride |
16221201 |
NSC736829 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
6-[2-(diethylamino)ethoxy]-9-methoxyindeno[1,2-c]quinolin-11-one |
54672977 |
NSC754242 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
6-hexyl-7-hydroxy-3-imidazo[1,2-a]pyridin-2-ylchromen-2-one |
5470855 |
NSC705895 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
7-(dimethylamino)-5-methylsulfanyl-2-thia-4,6,10,17-tetrazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(17),3,5,7,11,13,15-heptaen-9-ol |
394383 |
NSC697783 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
9-(oxan-2-yl)-1,3-diphenyl-2-sulfanylidenepurin-6-one |
387937 |
NSC682242 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Bis(dibenzylamino)methylideneurea;hydrochloride |
373929 |
NSC650958 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Bisbenzimide |
54600704 |
NSC334072 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
C18281 |
361185 |
NSC624114 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Copper;3-[18-(2-carboxyethyl)-3,7,12,17-tetramethylporphyrin-21,23-diid-2-yl]propanoic acid |
3844272 |
NSC18298 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Crotoxin cd |
|
NSC636009 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Deferoxamine hydrochloride |
2973 |
NSC268993 |
approved |
resistant |
|
|
|
|
hsa-miR-99a-5p |
Diethyl 2-[[4-[(3-ethoxycarbonylquinoxalin-2-yl)amino]benzoyl]amino]pentanedioate |
382848 |
NSC670678 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Diethyl 2-[[4-[[[3-ethoxycarbonyl-7-(trifluoromethyl)quinoxalin-2-yl]amino]methyl]benzoyl]amino]pentanedioate |
390810 |
NSC688812 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Dpbq |
364074 |
NSC629713 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Estramustine |
259331 |
NSC89201 |
approved |
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Ethyl 4-[6-(furan-2-yl)-2-methylsulfanyl-4-oxo-5H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
24205307 |
NSC734982 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Euchrysine |
62344 |
NSC194350 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
Fluvastatin |
1548972 |
NSC758896 |
approved |
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Gardenin |
261859 |
NSC94889 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Gsk1220512a |
25218614 |
NSC756140 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
Hydroxy at 125 |
5351254 |
NSC176324 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
Idaayixnilonem-uhfffaoysa-n |
393903 |
NSC696864 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
Imidazole, 1-(4-chlorophenyl)-4-(4-nitrophenyl)- |
355940 |
NSC610744 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
L06tdn89ab |
276876 |
NSC125347 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
Lovastatin |
53232 |
NSC633781 |
approved |
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Ls-150387 |
365515 |
NSC633203 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Ls-154710 |
380361 |
NSC665883 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
M-azidopyrimethamine |
343097 |
NSC382050 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
Methyl 2-[(2e)-2-[(2,6-dichlorophenyl)methylidene]hydrazinyl]-5-(3,4,5-trimethoxyphenyl)-1h-pyrrole-3-carboxylate |
45029264 |
NSC745940 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
N'-(2-chloroethyl)-N'-ethyl-N-(2-methoxyacridin-9-yl)ethane-1,2-diamine |
217470 |
NSC628114 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
N'-(2-chloroethyl)-N-(2-methoxyacridin-9-yl)-N'-methylpropane-1,3-diamine;hydrochloride |
362517 |
NSC626540 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
N'-[5-formyl-6-[5-(4-nitrophenyl)furan-2-yl]imidazo[2,1-b][1,3,4]thiadiazol-2-yl]sulfonyl-n,n-dimethylmethanimidamide |
9601324 |
NSC699670 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
N-(1,2,3-trihydroxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5h-benzo[a]heptalen-7-yl)benzamide |
369939 |
NSC642306 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
N-(4-chlorophenyl)-2-(3-phenylquinoxalin-2-yl)sulfanylacetamide |
16079750 |
NSC734278 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
N-(4-chlorophenyl)-5-[(e)-2-(2,5-dimethoxyphenyl)ethenyl]-1,3,4-oxadiazol-2-amine |
60147767 |
NSC752384 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
N-(4-methoxyphenyl)-3-[4-[(4-methylphenyl)diazenyl]-3,5-diphenylpyrazol-1-yl]-3-oxopropanamide |
367846 |
NSC637921 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
N-[(E)-(5-bromo-2-hydroxyphenyl)methylideneamino]-2-[6-(4-bromophenyl)imidazo[2,1-b][1,3]thiazol-3-yl]acetamide |
135585540 |
NSC732336 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
N-[(e)-benzylideneamino]-2-(3-benzyl-6-iodo-4-oxoquinazolin-2-yl)sulfanylacetamide |
9572422 |
NSC715740 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
N-methyl-2,4-dinitro-N-[(E)-quinolin-8-ylmethylideneamino]aniline |
9555808 |
NSC630684 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
N,n-dibenzyl-4-(4-hydroxy-2,6-dimethyl-5-pyrimidinyl)-1-piperazinesulfonamide |
135426540 |
NSC673104 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Naphth[2,3-d]oxazol-9-one, 2-methyl-4-(phenylimino)- |
160386 |
NSC650573 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Naphtho[1,2-b]quinolizinium, 10,13-dimethyl- chloride |
20245316 |
NSC78629 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
NSC618857 |
|
NSC618857 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
NSC664556 |
|
NSC664556 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
NSC688995 |
|
NSC688995 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
NSC709358 |
|
NSC709358 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
NSC762756 |
|
NSC762756 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Predorine |
333830 |
NSC337851 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
Tert-butyl 5-[[1-[[1-[2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-6-[(2-methylpropan-2-yl)oxycarbonylamino]-1-oxohexan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxopentanoate |
383820 |
NSC672437 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Tert-butyl N-[3-(5,11-dioxoindeno[1,2-c]isoquinolin-6-yl)propyl]carbamate |
11304253 |
NSC725047 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Thiopyrimidine-ch3 |
5473238 |
NSC724615 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
Trimethyl 2-phosphono-3-(2-furan)acrylate |
5467926 |
NSC660147 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Triphenylplumbyl 2-benzamidoacetate |
16683156 |
NSC628688 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Triphenylplumbyl 2-formamido-3-phenyl-propanoate |
16683158 |
NSC628690 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Tris(1,10-phenanthroline)cerium(iii)-trithiocyanate |
24202209 |
NSC632734 |
|
resistant |
|
|
|
|
hsa-miR-99a-5p |
Zinc;2-(3,4-dimethoxyphenyl)-5-hydroxy-3,7-dimethoxychromen-4-one |
|
NSC408171 |
|
sensitive |
|
|
|
|
hsa-miR-99a-5p |
Doxorubicin |
31703 |
NSC123127 |
approved |
resistant |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-99a-5p |
Verapamil |
2520 |
NSC272366 |
approved |
resistant |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-99a-5p |
Daunorubicin |
30323 |
NSC82151 |
approved |
resistant |
|
High |
Lymphoblastic Leukemia |
tissue |
hsa-miR-99a-5p |
Prednisolone |
5755 |
NSC9120 |
approved |
resistant |
|
High |
Lymphoblastic Leukemia |
tissue |
hsa-miR-99a-5p |
Vincristine |
5978 |
|
approved |
resistant |
|
High |
Lymphoblastic Leukemia |
tissue |
hsa-miR-99a-5p |
L-Asparaginase |
|
|
|
resistant |
|
High |
Lymphoblastic Leukemia |
tissue |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
High |
Germ Cell Tumor |
cell line (NTERA-2) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (SKOV3) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
High |
Esophageal Squamous Cell Carcinoma |
tissue and cell line (TE1, TE5, TE8, TE9, TE10, TE11, TE13) |
hsa-miR-99a-5p |
Vincristine |
5978 |
|
approved |
resistant |
|
Low |
Childhood Acute Lymphoblastic Leukemia |
Reh cells |
hsa-miR-99a-5p |
Oxaliplatin |
6857599 |
NSC266046 |
approved |
sensitive |
|
High |
Colorectal Cancer |
cell line (HCT-116) |
hsa-miR-99a-5p |
Fluorouracil |
3385 |
NSC19893 |
approved |
resistant |
|
High |
Colorectal Cancer |
tissue |
hsa-miR-99a-5p |
Oxaliplatin |
6857599 |
NSC266046 |
approved |
resistant |
|
High |
Colorectal Cancer |
tissue |
hsa-miR-99a-5p |
Fluorouracil + Oxaliplatin |
|
|
|
resistant |
|
High |
Colorectal Cancer |
tissue |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
High |
Ovarian Cancer |
cell line (C13*, A2780, OV2008) |
hsa-miR-99a-5p |
Docetaxel |
148124 |
NSC628503 |
approved |
resistant |
|
High |
Prostate Cancer |
cell line (DU-145) |
hsa-miR-99a-5p |
Fluorouracil |
3385 |
NSC19893 |
approved |
resistant |
|
High |
Pancreatic Cancer |
cell line (PANC-1) |
hsa-miR-99a-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
resistant |
|
High |
Pancreatic Cancer |
cell line (PANC-1) |
hsa-miR-99a-5p |
Chemotherapy |
|
|
|
sensitive |
|
High |
Colorectal Cancer |
tissue |
hsa-miR-99a-5p |
Gefitinib |
123631 |
NSC715055 |
approved |
resistant |
|
High |
Lung Adenocarcinoma |
cell line (A549) |
hsa-miR-99a-5p |
Taxane |
9548828 |
|
|
resistant |
|
High |
Prostate Cancer |
cell line (PC-3, PR70) |
hsa-miR-99a-5p |
Taxane |
9548828 |
|
|
resistant |
|
High |
Prostate Cancer |
cell line (PC-3, PR200) |
hsa-miR-99a-5p |
Taxane |
9548828 |
|
|
resistant |
|
High |
Prostate Cancer |
cell line (PC-3, PR20) |
hsa-miR-99a-5p |
Dexamethasone |
5743 |
NSC34521 |
approved |
sensitive |
|
High |
Myeloma |
cell line (MM1R, MM1S) |
hsa-miR-99a-5p |
Plx-4720 |
24180719 |
NSC757438 |
|
resistant |
|
High |
Thyroid Cancer |
cell line (8505c, BCPAP) |
hsa-miR-99a-5p |
Platinum |
23939 |
|
|
resistant |
|
High |
Ovarian Cancer |
tissue |
hsa-miR-99a-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
resistant |
|
Low |
Pancreatic Ductal Adenocarcinoma |
cell line (PANC-1, MIA-PaCa-2) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
Low |
Cervical Cancer |
tissue |
hsa-miR-99a-5p |
Aromatase Inhibitor |
|
|
|
sensitive |
|
Low |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
Low |
Gastric Cancer |
cell line (BGC823, SGC-7901) |
hsa-miR-99a-5p |
Dabrafenib |
44462760 |
NSC764134 |
approved |
sensitive |
|
High |
Melanoma |
cell line (A375, IGR37, 501Mel) |
hsa-miR-99a-5p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
sensitive |
|
High |
Melanoma |
cell line (A375, IGR37, 501Mel) |
hsa-miR-99a-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
sensitive |
|
High |
Non-Small Cell Lung Cancer |
cell line (A549) |
hsa-miR-99a-5p |
Imatinib |
5291 |
NSC743414 |
approved |
sensitive |
|
High |
Chronic Myelogenous Leukemia |
tissue |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
Low |
Urothelial Bladder Cancer |
cell line (T24) |
hsa-miR-99a-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
sensitive |
|
Low |
Urothelial Bladder Cancer |
cell line (T24) |
hsa-miR-99a-5p |
Fulvestrant |
17756771 |
NSC719276 |
approved |
resistant |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Gastric Cancer |
tissue |
hsa-miR-99a-5p |
Fluorouracil |
3385 |
NSC19893 |
approved |
resistant |
|
High |
Gastric Cancer |
tissue |
hsa-miR-99a-5p |
Cyclophosphamide + Doxorubicin + Vincristine + Prednisone + Rituximab |
|
|
|
resistant |
|
High |
Diffuse Large B-Cell Lymphoma |
cell line (SU-DHL-2) |
hsa-miR-99a-5p |
Radioactivity Iodine |
|
|
|
sensitive |
|
High |
Papillary Thyroid Cancer |
tissue |
hsa-miR-99a-5p |
Crizotinib |
11626560 |
NSC749005 |
approved |
resistant |
|
High |
Non-Small Cell Lung Cancer |
cell line (NCI-H2228, DFCI032) |
hsa-miR-99a-5p |
Lorlatinib |
71731823 |
NSC780108 |
approved |
resistant |
|
High |
Non-Small Cell Lung Cancer |
cell line (NCI-H2228, DFCI032) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
High |
Ovarian Cancer |
cell line (A2780) |
hsa-miR-99a-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (SKOV3) |
hsa-miR-99a-5p |
Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) |
|
|
|
resistant |
|
High |
Metastatic Colorectal Cancer |
tissue |
hsa-miR-99a-5p |
Temozolomide |
5394 |
NSC362856 |
approved |
sensitive |
|
High |
Glioma |
tissue |
hsa-miR-99a-5p |
Fluorouracil |
3385 |
NSC19893 |
approved |
resistant |
|
High |
Colorectal Cancer |
cell line (HT-29) |
hsa-miR-99a-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
sensitive |
|
High |
Pancreatic Cancer |
cell line (AsPC-1) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Gastric Cancer |
cell line (SGC-7901, BGC-823) |
hsa-miR-99a-5p |
Platinum |
23939 |
|
|
resistant |
|
High |
High-Grade Serous Ovarian Cancer |
tissue |
hsa-miR-99a-5p |
Rituximab |
|
|
|
resistant |
|
High |
Diffuse Large B-Cell Lymphoma |
cell line (DB, NU-DHL-1, NU-DUL-1, MC-116, SU-DHL-4, SU-DHL-5, FARAGE, HBL-1, OCI-Ly3, OCI-Ly7, OCI-Ly8, OCI-Ly19, RIVA, SU-DHL-8, U2932) |
hsa-miR-99a-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (W1) |
hsa-miR-99a-5p |
Taxane |
9548828 |
|
|
resistant |
|
Low |
Breast Cancer |
cell line (MCF-7, Bads-200, BCap37) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (A2780CIS) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
High |
Ovarian Cancer |
cell line (A2780CP20) |
hsa-miR-99a-5p |
Sorafenib |
216239 |
NSC747971 |
approved |
resistant |
|
High |
Hepatocellular Carcinoma |
cell line (HepG2) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (A2780) |
hsa-miR-99a-5p |
Osimertinib |
71496458 |
NSC779217 |
approved |
sensitive |
|
Low |
Non-Small Cell Lung Cancer |
cell line (H1975) |
hsa-miR-99a-5p |
Antiepileptic Drug |
|
|
|
sensitive |
|
High |
Pediatric Epilepsy |
tissue |
hsa-miR-99a-5p |
Gefitinib |
123631 |
NSC715055 |
approved |
resistant |
|
|
|
cell line (HCC827) |
hsa-miR-99a-5p |
Osimertinib |
71496458 |
NSC779217 |
approved |
sensitive |
|
|
|
cell line (PC9) |
hsa-miR-99a-5p |
Osimertinib |
71496458 |
NSC779217 |
approved |
sensitive |
|
|
|
cell line (HCC827) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (CAL-27) (total RNA) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (CAL-27) (cytosolic RNA) |
hsa-miR-99a-5p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
sensitive |
|
|
|
cell line (451Lu) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line |
hsa-miR-99a-5p |
Gefitinib |
123631 |
NSC715055 |
approved |
sensitive |
|
|
|
cell line (HCC827) |
hsa-miR-99a-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
|
|
cell line (HeyA8) |
hsa-miR-99a-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
sensitive |
|
|
|
cell line (SKVO3ip1) |
hsa-miR-99a-5p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
sensitive |
|
|
|
cell line (LM16) |
hsa-miR-99a-5p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
resistant |
|
|
|
cell line (LM47) |
hsa-miR-99a-5p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
resistant |
|
|
|
cell line (LM36) |
hsa-miR-99a-5p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
sensitive |
|
|
|
cell line (LM43) |
hsa-miR-99a-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
|
|
cell line (HS578T) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (A549) |
hsa-miR-99a-5p |
Tamoxifen+Fulvestrant |
|
|
|
resistant |
|
|
|
cell line (LCC9) |
hsa-miR-99a-5p |
Tamoxifen |
2733525 |
NSC180973 |
approved |
resistant |
|
|
|
cell line (LCC2) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (CP20) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (CIS) |
hsa-miR-99a-5p |
Exemestane |
60198 |
NSC713563 |
approved |
sensitive |
|
|
|
cell line (MCF-7) |
hsa-miR-99a-5p |
Testosterone+Anastrozole |
|
|
|
sensitive |
|
|
|
cell line (MCF-7) |
hsa-miR-99a-5p |
Testosterone+Exemestane |
|
|
|
sensitive |
|
|
|
cell line (MCF-7) |
hsa-miR-99a-5p |
Testosterone+Letrozole |
|
|
|
sensitive |
|
|
|
cell line (MCF-7) |
hsa-miR-99a-5p |
Osimertinib |
71496458 |
NSC779217 |
approved |
sensitive |
|
|
|
cell line (H1975) |
hsa-miR-99a-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
sensitive |
|
|
|
cell line (A2780) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (A2780) |
hsa-miR-99a-5p |
Fluorouracil |
3385 |
NSC19893 |
approved |
resistant |
|
|
|
cell line (HCT15) |
hsa-miR-99a-5p |
Ethanol+Tamoxifen |
|
|
|
resistant |
|
|
|
cell line (LY2) |
hsa-miR-99a-5p |
Fluorouracil |
3385 |
NSC19893 |
approved |
resistant |
|
|
|
cell line (KM12C) (72 h) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (RPMI2650) |
hsa-miR-99a-5p |
Sunitinib |
5329102 |
NSC750690 |
approved |
resistant |
|
|
|
tissue (CardA) |
hsa-miR-99a-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
resistant |
|
|
|
cell line (HuH28) |
hsa-miR-99a-5p |
Platinum |
23939 |
|
|
resistant |
|
|
|
tissue (non-small cell lung cancer) |
hsa-miR-99a-5p |
Oxaliplatin |
6857599 |
NSC266046 |
approved |
resistant |
|
|
|
cell line (IGROV-1) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (IGROV-1) |
hsa-miR-99a-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
|
|
cell line (PC3PR70) |
hsa-miR-99a-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
|
|
cell line (PC3PR20) |
hsa-miR-99a-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
|
|
cell line (PC3PR200) |
hsa-miR-99a-5p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
sensitive |
|
|
|
cell line (LM16) |
hsa-miR-99a-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
resistant |
|
|
|
cell line (PANC-1) (1500 ng/ml) |
hsa-miR-99a-5p |
Gemcitabine |
60750 |
NSC613327 |
approved |
resistant |
|
|
|
cell line (Panc1-GR4) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (A2780) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (OVCAR3) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (H23) |
hsa-miR-99a-5p |
Cetuximab |
|
|
|
resistant |
|
|
|
tissue (colorectal carcinoma) |
hsa-miR-99a-5p |
Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide |
|
|
|
sensitive |
|
|
|
cell line (Bads-200) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (TOV-112D) |
hsa-miR-99a-5p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (OVSAHO) |